ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Taipei City, TWN:

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer (DB-07)

DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Tucatinib
Drug: Durvalumab

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Taipei, Taiwan and 71 other locations

Chemotherapy-associated side-effects would affect therapeutic effect, quality of life, and cause permanent harm to breast cancer pa ...

Enrolling
Breast Cancer
Other: Placebo
Dietary Supplement: Probiotic
GenMont Biotech

Taipei, Taiwan

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 145 other locations

DESTINY-Breast 08 will investigate the safety, tolerability, PK and preliminary anti-tumour activity of T-DXd in combination with other ther ...

Active, not recruiting
Metastatic Breast Cancer
Drug: Fulvestrant
Drug: Durvalumab

Phase 1

AstraZeneca
AstraZeneca

Taipei, Taiwan and 36 other locations

Olaparib, a PARP inhibitor, is proven as an effective therapy for germline BRCA1/2-mutated breast cancer; however, the therapeutic ...

Enrolling
Metastatic Breast Cancer
Drug: Olaparib
Drug: Chemotherapy drug

Phase 2

National Taiwan University
National Taiwan University

Taipei, Please Select, Taiwan and 2 other locations

in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast...

Active, not recruiting
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Trastuzumab deruxtecan

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Taipei, Taiwan and 31 other locations

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....

Enrolling
Advanced Breast Cancer
Drug: ARV-471
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Taipei, Taiwan and 446 other locations

how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast...

Active, not recruiting
Hormone Receptor Positive Breast Cancer
Drug: faslodex dummy
Drug: arimidex dummy

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 118 other locations

with inoperable or metastatic HR-positive, HER2- negative breast cancer who have been treated with one or two prior lines of...

Active, not recruiting
Breast Cancer
Drug: Eribulin
Drug: Vinorelbine

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 166 other locations

study drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast...

Active, not recruiting
Endometrial Cancer
Breast Cancer
Drug: Trastuzumab
Drug: Everolimus

Phase 1

Lilly
Lilly

Taipei, Taiwan and 73 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems